The global liver fibrosis treatment market is poised for substantial growth, with revenue projections increasing from USD 17.51 billion in 2024 to USD 51.16 billion by 2033. This expansion represents ...

Hepatic steatosis, often triggered by non-alcoholic fatty liver disease (NAFLD), is a leading cause of liver dysfunction globally, affecting approximately 30% of the population.

The review aims to explore how these transporters influence the pathophysiological processes underlying liver diseases, focusing on their roles in lipid metabolism, hepatocyte function, and the ...

Solute carrier (SLC) family transporters are crucial transmembrane proteins responsible for transporting various molecules, including amino acids, electrolytes, fatty acids, and nucleotides. To date, ...

Viral infections are a predominant cause of liver disease around the world, impacting millions with conditions ranging from mild inflammation to severe ...

Insulin is a hormone that allows glucose in the blood to enter cells, providing them with the energy to function. A lack of adequate insulin plays a key role in the development of diabetes.

College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, P.R. China Key Laboratory of the Provincial Education Department of Heilongjiang for Common Animal Disease Prevention ...

By injecting modified si-RNAs, they demonstrated that Lhx2 knockdown impaired hepatocyte proliferation and liver function recovery after acute injury. Additionally, using Lrat-cre (HSC-specific ...